Propofol increases the rate of albumin-unbound free midazolam in serum albumin solution

Jun Ohmori, Shigeru Maeda, Hitoshi Higuchi, Minako Ishii, Yukiko Arai, Yumiko Tomoyasu, Atsushi Kohjitani, Masahiko Shimada, Takuya Miyawaki

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


Propofol and midazolam have a synergistic anesthetic action. One of the reasons for this is thought to be the inhibitory effect of propofol on midazolam metabolism. However, because both drugs bind strongly to serum protein, their interaction may not only involve the effects of propofol on midazolam metabolism, but may also involve propofol's effects on serum protein-binding. Against this background, we investigated the characteristics of midazolam binding to serum albumin, and evaluated the effects of both propofol and ketamine on this binding. Midazolam was added to a serum albumin solution with propofol or ketamine, and, after incubation for 1 h, albumin-free solution was separated from the sample and the midazolam concentration was measured using a high-performance liquid chromatography system. The albumin-unbound rate of midazolam was evaluated and compared with the rate in the control solution (only midazolam). Propofol significantly raised the rate of albumin-unbound free midazolam, while ketamine had no effect on the binding of midazolam to serum albumin. These findings suggest that the increase in albumin-unbound free midazolam brought about by propofol is involved in the synergistic effect of these two agents.

Original languageEnglish
Pages (from-to)618-620
Number of pages3
JournalJournal of Anesthesia
Issue number4
Publication statusPublished - Aug 2011


  • Midazolam
  • Pharmacokinetics
  • Propofol
  • Protein-binding

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Propofol increases the rate of albumin-unbound free midazolam in serum albumin solution'. Together they form a unique fingerprint.

Cite this